Le Lézard

PADCEVtm Plus KEYTRUDAtm, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...
Taiwan News

Dassault Systèmes: Solid third quarter with strong operational performance: Confirming full-year EPS growth on adjusted revenue outlook

Pascal Daloz, Dassault Systèmes’ Chief Executive Officer, commented: ...

Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc

Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have entered into a definitive agreement under which Alkermes will ...

Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.
The Manila Times

FungaBeam LLLT Device Disrupts $3.2B Nail Fungus Market with 85% Cost Savings as Americans Waste $500M Annually on Ineffective Treatments

FDA-Registered Home Laser Technology Gains Rapid Adoption During Winter Season as Year-End HSA/FSA Deadlines Drive 290% Search Surge-Podiatrists Report Clinical-Grade Results Without $2,500+ Professio ...

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.